VALEANT PHARMACEUTICALS INTL's ticker is VRX and the CUSIP is 91911K102. A total of 333 filers reported holding VALEANT PHARMACEUTICALS INTL in Q4 2016. The put-call ratio across all filers is 1.34 and the average weighting 0.3%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2018 | $12,485,000 | -19.0% | 784,818 | +6.5% | 0.51% | -23.1% |
Q4 2017 | $15,405,000 | +1.7% | 736,718 | -30.5% | 0.67% | +16.6% |
Q3 2017 | $15,145,000 | -22.2% | 1,059,318 | -5.5% | 0.57% | -21.3% |
Q2 2017 | $19,458,000 | +46.3% | 1,121,113 | -7.2% | 0.73% | +41.4% |
Q1 2017 | $13,304,000 | -7.2% | 1,207,818 | +22.4% | 0.51% | -12.0% |
Q4 2016 | $14,332,000 | -15.5% | 987,118 | +42.6% | 0.58% | -4.3% |
Q3 2016 | $16,952,000 | +11.5% | 692,118 | -8.7% | 0.61% | +0.2% |
Q2 2016 | $15,210,000 | +31.4% | 758,300 | +72.5% | 0.61% | +33.6% |
Q1 2016 | $11,575,000 | -40.8% | 439,700 | +127.5% | 0.46% | -46.0% |
Q4 2015 | $19,560,000 | +128.7% | 193,300 | +301.5% | 0.84% | +153.0% |
Q3 2015 | $8,553,000 | -38.9% | 48,144 | -23.7% | 0.33% | -34.6% |
Q2 2015 | $14,004,000 | +148.7% | 63,100 | +121.4% | 0.51% | +197.1% |
Q1 2015 | $5,631,000 | +503.5% | 28,500 | +338.5% | 0.17% | +454.8% |
Q4 2014 | $933,000 | +72.8% | 6,500 | +58.5% | 0.03% | +14.8% |
Q1 2014 | $540,000 | -95.7% | 4,100 | -96.2% | 0.03% | -95.8% |
Q4 2013 | $12,491,000 | -22.1% | 106,500 | -30.6% | 0.64% | -28.7% |
Q3 2013 | $16,039,000 | +106.6% | 153,500 | +70.0% | 0.90% | +75.9% |
Q2 2013 | $7,762,000 | – | 90,300 | – | 0.51% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
ACCIPITER CAPITAL MANAGEMENT, LLC | 2,106,379 | $55,398,000 | 31.67% |
Claren Road Asset Management, LLC | 80,000 | $2,820,000 | 24.27% |
Okumus Fund Management Ltd. | 3,722,464 | $97,901,000 | 15.82% |
Wingspan Investment Management, LP | 852,900 | $22,431,000 | 12.66% |
FARLEY CAPITAL L.P. | 307,458 | $8,086,000 | 11.46% |
Chou Associates Management | 976,843 | $25,725,000 | 8.35% |
Wingspan Investment Management, LP | 550,700 | $14,483,000 | 8.17% |
HAP Trading, LLC | 4,043,900 | $109,610,000 | 8.00% |
LeVasseur Capital Partners LLC | 128,269 | $3,373,000 | 6.97% |
Pershing Square Capital Management | 21,591,122 | $567,847,000 | 6.41% |